CG Oncology, Inc.
- Stock
- Ticker CGON
- Nasdaq
Performance, volatility and drawdowns of CG Oncology, Inc. since 01/2024, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $21,380. Global equities (VT): $14,390.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −67.5% in 04/2025, measured from the peak in 02/2024. It took 23 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 0.5 | 0.1 | 0.0 | 1.7 | 2.3 | 1.1 | 1.2 | 1.6 |
| Gross profit | – | – | – | 0.1 | – | – | – | -1.1 |
| Operating income | -38 | -42 | -49 | -51 | -49 | -66 | -86 | -63 |
| EBITDA | -38 | -42 | -49 | -51 | -48 | -66 | -86 | -62 |
| Net income | -32 | -34 | -41 | -44 | -41 | -60 | -79 | -57 |
| Earnings per share | -0.48 | -0.45 | -0.54 | -0.57 | -0.51 | -0.71 | -0.90 | -0.64 |
| Balance sheet | ||||||||
| Total assets | 755 | 728 | 701 | 730 | 792 | 1,135 | 1,086 | 1,047 |
| Liabilities | 21 | 23 | 31 | 42 | 39 | 43 | 57 | 56 |
| Equity | 733 | 705 | 670 | 688 | 753 | 1,092 | 1,029 | 991 |
| Cash | 257 | 41 | 15 | 45 | 32 | 34 | 20 | 28 |
| Long-term debt | 0.0 | – | – | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 |
| Cash flow | ||||||||
| Operating cash flow | -21 | -29 | -28 | -39 | -36 | -57 | -46 | -48 |
| Capital expenditure | -0.2 | 0.0 | 0.0 | -0.1 | 0.0 | -0.3 | -0.5 | -1.1 |
| Free cash flow | -21 | -29 | -28 | -39 | -36 | -57 | -47 | -49 |
Value it:DCF calculatorMultiples calculator
Annual returns
* partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 6 Nov 2026 | −$0.64 |
| 6 Aug 2026 | −$0.90 |
| 8 May 2026 | −$0.71 |
| 27 Feb 2026 | −$0.51 |
| 14 Nov 2025 | −$0.57 |
| 8 Aug 2025 | −$0.54 |
| 13 May 2025 | −$0.45 |
| 28 Mar 2025 | −$0.48 |
| 12 Nov 2024 | −$0.30 |
| 8 Aug 2024 | −$3.93 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €6.4bn
- Market cap in trading currency
- $7.10bn
- Enterprise value
- $6.12bn
- P/E
- –
- P/S
- 1,151.18
- P/B
- 7.16
- EV/Sales
- 992.01
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -2.7%
Results (last four quarters)
- Revenue
- $6.17m
- Gross profit
- –
- EBITDA
- −$261m
- Net income
- −$237m
- Earnings per share
- −$2.76
- Revenue per share
- $0.07
- Revenue growth
- −3.7%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- -4,293.5%
- Net margin
- -3,851.1%
- Return on equity
- -28.3%
- Return on assets
- -22.7%
Balance sheet and cash flow
- Cash
- $984m
- Cash per share
- $11.02
- Financial debt
- $3.00m
- Debt/equity %
- 0
- Current ratio
- 21.70
- Book value per share
- $11.09
- Operating cash flow
- −$187m
- Free cash flow
- −$189m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 89.3m
- Volume
- 1.67m
- Avg. volume 3 months
- 1.00m
- Relative volume
- 1.4
Price and technicals
- Price
- $79.47
- 1 day
- −3.0%
- 52-week high
- $84.78
- 52-week low
- $37.37
- Distance to 52-week high
- −6.3%
- Distance to 52-week low
- +112.7%
- Distance to 50-day line
- +15.4%
- Distance to 200-day line
- +17.9%
- RSI (14)
- 60
- Volatility 1M
- 88.0%
Performance
- 1 week
- +6.8%
- 1 month
- +27.1%
- 3 months
- +1.6%
- 6 months
- +23.7%
- YTD
- +91.4%
- 1 year
- +86.5%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has CGON performed since 01/2024?
$10,000 grew to $21,380 by 20 Nov 2026, which is +30.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is CGON?
Volatility was 46.7% per year, measured on monthly returns. The largest decline from a peak was −67.5%, with the low in 04/2025.
How does CGON compare with a broad equity ETF?
Over the same period Global equities (VT) returned +13.8% per year at 12.3% volatility, CGON returned +30.9% at 46.7%. The correlation of monthly returns was 0.00; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.